Inflammation as a Predictor in Cardioversion of Atrial Fibrillation

C

Creighton University

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Procedure: Cardioversion

Study type

Observational

Funder types

Other

Identifiers

NCT00590525
04-13547

Details and patient eligibility

About

The laboratory test, C-Reactive Protein (CRP), has become well established as a marker of inflammation. Recently a high CRP level (indicating an increase in inflammation) was identified as a risk factor for atrial fibrillation. We are conducting this study with patients such as yourself with atrial fibrillation who are planning to undergo cardioversion to determine what sort of relationship exists between CRP levels and atrial fibrillation. We will then look at success rates of converting atrial fibrillation to normal sinus rhythm, compared to patients' CRP levels.

Enrollment

45 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Atrial fibrillation patients referred for DC cardioversion
  • On stable medical therapy

Exclusion Criteria

  • Known chronic inflammatory states such as infections, rheumatoid arthritis or known vasculitides.
  • Patients having undergone recent surgery or who are on steroid therapy for any reason will be excluded.

Trial design

45 participants in 1 patient group

1
Treatment:
Procedure: Cardioversion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems